Showing results (541-550 of 552) with videos related to
Sort By:
Pageof 56
Molecular Therapy. Nucleic Acids|March 23, 2016
A Small Indel Mutant Mouse Model of Epidermolytic Palmoplantar Keratoderma and Its Application to Mutant-specific shRNA TherapyYa-Su Lyu, Pei-Liang Shi, Xiao-Ling Chen, et al.Toxicology and Applied Pharmacology|November 6, 2013
Growth inhibitory effect of KYKZL-1 on Hep G2 cells via inhibition of AA metabolites and caspase-3 pathway and cell cycle arrestJing Cheng, Yi-Fang Du, Zhi-Yi Xiao, et al.Arthritis and Rheumatism|July 1, 2009
Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexateLiang-Jing Lu, Chun-de Bao, Min Dai, et al.Molecular Therapy. Methods & Clinical Development|September 13, 2021
Depletion of high-content CD14+ cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturingXiuyan Wang, Oriana Borquez-Ojeda, Jolanta Stefanski, et al.Thyroid : Official Journal of the American Thyroid Association|December 6, 2012
RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in ChinaXiao-Ping Qi, Xiao-Ling Chen, Ju-Ming Ma, et al.Gene|December 26, 2012
Genetic diagnosis of autosomal dominant polycystic kidney disease by targeted capture and next-generation sequencing: utility and limitationsXiao-Ping Qi, Zhen-Fang Du, Ju-Ming Ma, et al.Elife|August 25, 2022
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variantsJing Zhang, Zi Bo Han, Yu Liang, et al.Nature Medicine|January 4, 2022
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trialFarid Boulad, Aurelio Maggio, Xiuyan Wang, et al.Nature|April 24, 2025
BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injuryWei Ruan, Tao Li, In Hyuk Bang, et al.Cell Discovery|February 16, 2022
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2Yu Liang, Jing Zhang, Run Yu Yuan, et al.Pageof 56